SCHEMBL5154832

SCHEMBL5154832

CCCCCCCCCCCCNC(CC(=O)O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.50
NOD1 Q9Y239 2/20 0.49
GPR84 Q9NQS5 6/20 0.47
EPHX1 P07099 4/20 0.44
PPARG P37231 3/20 0.42
PPARD Q03181 3/20 0.42
PPARA Q07869 3/20 0.42
TSHR P16473 2/20 0.42
HDAC11 Q96DB2 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
ALDH1A1 P00352 1/20 0.42
SLC22A6 Q4U2R8 1/20 0.42
SLC22A8 Q8TCC7 1/20 0.42
TLR2 O60603 1/20 0.42
MEN1 O00255 1/20 0.42
ESR1 P03372 1/20 0.42
FABP4 P15090 1/20 0.42
ALOX15 P16050 1/20 0.42
PTPN1 P18031 1/20 0.42
PDE4A P27815 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001495 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL29690808 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL29208288 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL25254866 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL7626586 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL25254864 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL1990411 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL7572383 1.00 EPHX2 (0.50) EPHX2NOD1GPR84EPHX1PPARG
SCHEMBL31243226 0.98 EPHX2 (0.49) EPHX2NOD1GPR84EPHX1PPARG
Potassium SCHEMBL31243229 0.98 EPHX2 (0.49) EPHX2NOD1GPR84EPHX1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117965145-A Capsule curing agent for delaying resin curing and preparation method and application thereof 中国石油大学(华东) 2024-05-03 CN claimed
EP-1159334-B1 PROCESS FOR THE MANUFACTURE OF FUNCTIONALIZED POLYPHENYLENE ETHERS GEN ELECTRIC (US) 2007-01-17 EP claimed
US-6417274-B1 OXIDATIVE COUPLING IN SOLUTION OF MONOVLENT PHENOL USING OXYGEN CONTAINING GAS; CATALYSIS WITH METAL COMPLEX; FUNCTIONALIZING POLYPHENYLENE ETHER DURING ISOLATION STEP FOR DEVOLATILIZATION GENERAL ELECTRIC CO. 2002-07-09 US claimed
US-5120801-A Impact strength, ductility GENERAL ELECTRIC CO. (US) 1992-06-09 US claimed
JP-10330232-A None JP disclosed
US-20250017833-A1 MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF INT FLAVORS & FRAGRANCES INC (US) 2025-01-16 US disclosed
EP-4419070-A1 MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF International Flavors & Fragrances Inc. (US) 2024-08-28 EP disclosed
CN-117965145-B Capsule curing agent for delaying resin curing and preparation method and application thereof 中国石油大学(华东) 2024-07-05 CN disclosed
CN-118119372-A Malodor-counteracting compositions, compositions and uses thereof 国际香料和香精公司 2024-05-31 CN disclosed
CN-117965145-A Capsule curing agent for delaying resin curing and preparation method and application thereof 中国石油大学(华东) 2024-05-03 CN disclosed
WO-2023069548-A1 MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF INTERNATIONAL FLAVORS AND FRAGRANCES INC. (US) 2023-04-27 WO disclosed
CN-106498724-A A kind of high-temperature resistant water dissolubility refining agent 无锡市华诚印染剂厂 2017-03-15 CN disclosed
EP-0260314-A1 POLYPHENYLENE ETHER/POLYAMIDE BLENDS HAVING IMPROVED PHYSICAL PROPERTIES. GEN ELECTRIC (US) 1988-03-23 EP disclosed
EP-0258421-A1 IMPACT MODIFIED POLYPHENYLENE ETHER-POLYAMIDE COMPOSITIONS. GEN ELECTRIC (US) 1988-03-09 EP disclosed
EP-0237948-A1 Methods for preparation of polyphenylene ether-polyamide compositions GENERAL ELECTRIC COMPANY (US) 1987-09-23 EP disclosed
EP-0236593-A1 Polymer mixture which comprises a polyamide, a polyphenylene ether and an agent to improve the impact strength GENERAL ELECTRIC COMPANY (US) 1987-09-16 EP disclosed
WO-1987005304-A1 POLYPHENYLENE ETHER/POLYAMIDE BLENDS HAVING IMPROVED PHYSICAL PROPERTIES THE GENERAL ELECTRIC COMPANY (US) 1987-09-11 WO disclosed
WO-1987005311-A1 IMPACT MODIFIED POLYPHENYLENE ETHER-POLYAMIDE COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 1987-09-11 WO disclosed
EP-0185054-A1 GEN ELECTRIC 1986-06-25 EP disclosed
WO-1985005372-A1 MODIFIED POLYPHENYLENE ETHER-POLYAMIDE COMPOSITIONS AND PROCESS GENERAL ELECTRIC COMPANY (US) 1985-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250017833-A1 MALODOR-COUNTERACTING COMPOUNDS, COMPOSITIONS, AND USES THEREOF MAL2, LPO, SMURF1 EPHX2 2368/4885NOD1 4572/4885GPR84 1449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.